BeStock  

BioCryst Pharmaceuticals BCRX

US equityMarket cap rank #2720Drug Manufacturers - Specialty & Generic
$7.22 −$0.10 (-1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.10 -1.66%
Open$7.26
Prev close$7.32
Day range$7.15 – $7.39
Volume3.85M
Market cap$1.86B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$17.00+135.5% vs. price
  • Buy 67%
  • Hold 33%
Low $11.00Now $7.22Avg $17.00High $30.00

Recent rating changes

The last 20 actions on file set price targets from $11.00 to $32.00, averaging $18.15.

DateFirmRatingTarget
5 Nov 2026 Wedbush BUY $17.00
4 Nov 2026 RBC Capital HOLD $11.00
21 Oct 2026 TD Cowen BUY $30.00
9 Oct 2026 BofA Securities BUY $15.00
8 Oct 2026 RBC Capital HOLD $11.00
30 Sep 2026 J.P. Morgan HOLD $13.00
10 Sep 2026 RBC Capital HOLD $11.00
8 Sep 2026 Needham BUY $16.00
6 Aug 2026 Wedbush BUY $20.00
6 Aug 2026 H.C. Wainwright BUY $32.00
5 Aug 2026 TD Cowen BUY $30.00
5 Aug 2026 Needham BUY $16.00
5 Aug 2026 RBC Capital BUY $13.00
15 Jul 2026 BofA Securities BUY $15.00
13 Jul 2026 Wedbush BUY $21.00
13 Jul 2026 J.P. Morgan HOLD $12.00
7 Jul 2026 RBC Capital BUY $14.00
30 Jun 2026 Cantor Fitzgerald BUY $29.00
30 Jun 2026 Wedbush BUY $21.00
30 Jun 2026 Needham BUY $16.00

Discussion

No comments yet — be the first to weigh in on BCRX.

Sign in to join the discussion.

Scroll to Top